Virtual Medicinal Product (VMP)
-
Leuprorelin 11.25mg powder and solvent for suspension for injection vials
Name Details
Current Name
Leuprorelin 11.25mg powder and solvent for suspension for injection vials
|
Start Date
09-09-2004
|
End Date
|
Previous Name
Leuprorelin 11.25mg powder and solvent for suspension for injection vial
|
Start Date
04-06-2004
|
End Date
08-09-2004
|
|
Abbreviated Name
Leuprorelin 11.25mg inj vials
|
Start Date
01-05-2009
|
|
Leuprorelin 11.25mg pdr & solv for susp for inj vials |
Previous Start Date
09-09-2004
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous, Intramuscular
- Form
- Powder and solvent for suspension for injection
- Ontology Form/Route
- suspensioninjection.subcutaneous, suspensioninjection.intramuscular
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L02AE02
BNF |
Current BNF
08030402
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08030402
|
Start Date
14-02-2005
|
End Date
03-04-2022
|
Previous BNF
06070200
|
Start Date
14-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
36038211000001102 |
29-10-2018 |
|
327361002 |
22-12-2002 |
28-10-2018 |
VMP Ingredients
Name
Leuprorelin acetate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
11.25
Strength and UOM (Dmr)
Parent Products
-
VTM
Leuprorelin
-
VMP
(Current) Leuprorelin 11.25mg powder and solve...
Virtual Medicinal Product Pack (VMPP) Information